ARDT

Ardent Health Partners, Inc.
ARDT
Market cap $2.78B

19.50 USD

-0.69

3.42%

At close Oct 17, 4:00 PM EDT

1 day

-3.42%

5 days

5.52%

1 month

13.24%

3 months

21.42%

6 months

21.42%

Year to date

21.42%

1 year

21.42%

5 years

21.42%

About: Ardent Health Partners Inc is an operator of hospitals and a provider of healthcare services in the United States. It provide both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. The company has one reportable segment: healthcare services that provides healthcare services primarily through its ownership and operation of hospitals, certain of which provide related healthcare services through physician practices, outpatient centers, and post-acute facilities. Ardent has 30 acute care hospitals, more than 200 sites of care that operates across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas.

Healthcare General Medical & Surgical Hospitals

–

Funds holding %

of 6,740 funds

0

Analysts bullish %

of 14 analysts

Fund manager confidence

See Fund Rankings

Research analyst outlook

14 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$18

8%

downside

Avg. target

$22

13%

upside

High target

$27

38%

upside

14 analyst ratings

13 positive

93%

1 neutral

7%

0 negative

0%

Keybanc Matthew Gillmor 67% 1-year accuracy 6 / 9 met price target	23%upside $24	Overweight Initiated	11 Oct 2024
Stephens & Co. Scott Fidel 82% 1-year accuracy 28 / 34 met price target	23%upside $24	Overweight Reiterated	19 Sept 2024
Truist Securities David Macdonald 76% 1-year accuracy 31 / 41 met price target	13%upside $22	Buy Reiterated	16 Aug 2024
Loop Capital Timothy Greaves 100% 1-year accuracy 2 / 2 met price target	8%upside $21	Buy Maintained	16 Aug 2024
Stephens & Co. Scott Fidel 82% 1-year accuracy 28 / 34 met price target	23%upside $24	Overweight Reiterated	15 Aug 2024

See Analyst Rankings

Financial journalist opinion

Based on 3 articles about ARDT published over the past 30 days

Ardent Health Partners With Qventus to Drive Strategic Perioperative Growth

NEW YORK--(BUSINESS WIRE)--Qventus, an industry titan in AI-based software that automates care operations, announced today that Ardent Health, a leading provider of healthcare services in communities across the country, has chosen Qventus' Perioperative Solution to optimize its robotics program and drive strategic surgical growth. The unique solution optimizes surgeries by intelligently marketing operating room (OR) time to surgeons based on strategic objectives and personalized surgeon pattern.

Ardent Health Partners With Qventus to Drive Strategic Perioperative Growth

Ardent Health Added to Russell 2000® and 3000® Indexes

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT) has been added as a member of the broad-market Russell 3000® Index and Russell 2000®, effective Monday, September 23, 2024, as part of the quarterly U.S. Russell Index Initial Public Offering (IPO) update. “We are pleased to join the Russell 3000® Index and look forward to building awareness around the Ardent growth story while increasing our exposure to new investor audiences,” said Ardent President and Chief Executive Officer Marty.

Ardent Health Added to Russell 2000® and 3000® Indexes

Ardent Health Completes Term Loan Repricing

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT) today announced it has entered into an amendment to its term loan credit agreement with its lenders to reprice its term loans. The repricing reduces the applicable interest rate by 50 basis points from Term Secured Overnight Financing Rate (SOFR) plus 3.25% to Term SOFR plus 2.75%, as well as eliminates the credit spread adjustment. There are no changes to the maturity of the loans following the repricing and all other terms are subs.

Ardent Health Completes Term Loan Repricing

Ardent Health Appoints Dave Styblo to Lead Investor Relations

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT) today announced the appointment of Dave Styblo as senior vice president of investor relations. In his new role, Styblo will oversee Ardent's investor relations program and serve as the primary liaison with investors, analysts and financial partners. Styblo brings more than 20 years of investment experience, including time as a sell-side analyst covering the healthcare industry. He previously served as a senior vice president at Jeffe.

Ardent Health Appoints Dave Styblo to Lead Investor Relations

Ardent Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health Partners, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the Company will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference being held September 4-6, 2024, in New York, NY. Ardent Health President and Chief Executive Officer Marty Bonick and Chief Financial Officer Alfred Lumsdaine will take part in a fireside c.

Ardent Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Ardent Health Reports Second Quarter 2024 Results

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health Partners, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Summary (All comparisons versus the same prior year period, unless otherwise noted) Total revenue of $1.47 billion, an increase of 7.5% Net income of $67 million Net income attributable to Ardent Hea.

Ardent Health Reports Second Quarter 2024 Results

New Hospital Operator On The Block Ardent Health Garners Interest As Analysts Initiate With Bullish View

In July, Ardent Health Partners Inc. ARDT closed its initial public offering of 12 million at a public offering price of $16 per share, for total gross proceeds of approximately $192 million.

New Hospital Operator On The Block Ardent Health Garners Interest As Analysts Initiate With Bullish View

Ardent Health Announces Second Quarter 2024 Results Conference Call and Webcast Date

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health Partners, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced that it will issue its second quarter 2024 results after the market closes on Wednesday, August 14, 2024. A conference call will be held the following day, Thursday, August 15, 2024, at 10:00 a.m. ET to review the Company's financial results, discuss recent events and conduct a ques.

Ardent Health Announces Second Quarter 2024 Results Conference Call and Webcast Date

U.S. IPO Weekly Recap: Insurance And Healthcare Lead A 4 IPO Week

A handful of IPOs priced this past week, led by three sizable names. One large issuer joined both the pipeline and the calendar - Chile-based LATAM Airlines Group. Six IPOs are scheduled to list in the week ahead and are set to raise a combined $5.1 billion, the most for any week so far this year. One SPAC is also set to debut.

U.S. IPO Weekly Recap: Insurance And Healthcare Lead A 4 IPO Week

Ardent Health Announces Closing of Its Initial Public Offering

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health Partners, Inc. (NYSE: ARDT) (f/k/a Ardent Health Partners, LLC and collectively “Ardent Health” or the “Company”), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced the closing of its initial public offering (the “Offering”) of 12,000,000 shares of its common stock sold by the Company at a public offering price of $16 per share, for total gross proceeds of approximately $192 million, before ded.

Ardent Health Announces Closing of Its Initial Public Offering

See News Rankings

Charts implemented using Lightweight Charts™